Skip to Content

Taihe Group Inc TIHE Stock Quote

| Rating as of

Morningstar‘s Stock Analysis TIHE

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics TIHE

Company Profile TIHE

Business Description

Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.

Contact
4870 Haygood Road, Suite 107
Virginia Beach, VA, 23455
T +1 757 554-0926
Industry Diagnostics & Research
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type
Employees 1